This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Jens To Andersen: Innovator in Microbial Transglutaminases
Introduction
Jens To Andersen is a notable inventor based in N.ae butted.rum, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of microbial transglutaminases. His work has implications for various industries, including food and pharmaceuticals.
Latest Patents
Andersen holds a patent for "Microbial transglutaminases, their production and use." This innovation highlights his expertise in enzyme technology and its applications in enhancing food products and processes. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.
Career Highlights
Jens To Andersen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His contributions to the company reflect his dedication to innovation in the biotechnology sector.
Collaborations
Andersen collaborates with talented colleagues, including Lisbeth Bech and Grethe Norskov Rasmussen. These partnerships foster a creative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Jens To Andersen is a distinguished inventor whose work in microbial transglutaminases exemplifies the intersection of science and innovation. His contributions to Novo Nordisk and the broader biotechnology field underscore the importance of collaboration and creativity in driving advancements.